PTH and osteoporosis: For instance, the T cell costimulatory factor CD40L has been reported to intensify the dysregulation of bone resorption and formation under both estrogen deficiency and continuous PTH treatment through stimulating the additional production of RANKL and inhibiting the secretion of OPG, thus leading to osteoporosis (43, 44).